Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort

Dementia and Geriatric Cognitive Disorders

Volumn 35, Issue 5-6, 2013, Pages 340-350

  Janicki, S C ^a,b,c   Park, N ^a,b   Cheng, R ^a,b   Schupf, N ^a,b,c   Clark, L N ^a,c,d   Lee, J H ^a,b,d  

^a NewYork Presbyterian Hospital   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Department of Neurology ^*  (United States)

^d Department of Psychiatry ^*  (United States)

Author keywords

Alzheimer's disease; Alzheimer's disease and Hispanics; CYP19 gene; Estrogen; Genetic polymorphisms in degenerative dementias; Genetic risk factors

Indexed keywords

APOENZYME; AROMATASE;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; EDUCATION; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876797916     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000343074     Document Type: Article

References (31)

1. Shughrue PJ, Lane MV, Merchenthaler I: Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 1997; 388: 507-525.
2. McEwen BS: Invited review: estrogen effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91: 2785-2801.
3. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmuller D: Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol 1999; 70: 237-241.
4. Huang R, Poduslo SE: CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet 2006; 43:e42.
5. Iivonen S, Corder E, Lehtovirta M, Helisalmi S, Mannermaa A, Vepsalainen S, Hanninen T, Soininen H, Hiltunen M: Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 2004; 62: 1170-1176.
6. Butler HT, Warden DR, Hogervorst E, Ragoussis J, Smith AD, Lehmann DJ: Association of the aromatase gene with Alzheimer's disease in women. Neurosci Lett 2010; 468: 202-206.
7. Corbo RM, Gambina G, Ulizzi L, Moretto G, Scacchi R: Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women. Dement Geriatr Cogn Disord 2009; 27: 513-518.
8. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007; 39: 17-23.
9. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R: Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56: 49-56.
10. Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R, Mayeux R: Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992; 49: 453-460.
11. Pritchard JK, Stephens M, Donnelly P: Inference of population structure using multilocus genotype data. Genetics 2000;155: 945-959.
12. Falush D, Stephens M, Pritchard JK: Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003; 164: 1567-1587.
13. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhai. J Lipid Res 1990; 31: 545-548.
14. Goodman Y, Bruce AJ, Cheng B, Mattson MP: Estrogens attenuate and corticosterone exacerbates excitotox-icity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836-1844.
15. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ: Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal fore-brain. Proc Natl Acad Sci USA 1992; 89: 4668-4672.
16. Luine VN: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484-490.
17. Behl C, Widmann M, Trapp T, Holsboer F: 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216: 473-482.
18. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE: Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994; 269: 13065-13068.
19. Gerhard M, Ganz P: How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation 1995; 92: 5-8.
20. Simoncini T, Mannella P, Genazzani AR: Rapid estrogen actions in the cardiovascular system. Ann NY Acad Sci 2006; 1089: 424-430.
21. Ishunina TA, Fischer DF, Swaab DF: Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging 2007; 28: 1670-1681.
22. Ishunina TA, van Beurden D, van der Meulen G, Unmehopa UA, Hol EM, Huitinga I, Swaab DF: Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging 2005; 26: 173-194.
23. Stoffel-Wagner B, Watzka M, Steckelbroeck S, Schwaab R, Schramm J, Bidlingmaier F, Klingmuller D: Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochem Biophys Res Commun 1998; 244: 768-771.
24. Yague JG, Munoz A, de Monasterio-Schrader P, Defelipe J, Garcia-Segura LM, Azcoitia I: Aromatase expression in the human temporal cortex. Neuroscience 2006; 138: 389-401.
25. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A: Association of CYP17, CYP19, CYP1b1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13: 94-101.
26. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA: Polymorphisms associated with circulating sex hormone levels in postmeno-pausal women. J Natl Cancer Inst 2004; 96: 936-945.
27. De Castro F, Moron FJ, Montoro L, Galan JJ, Real LM, Ruiz A: Re: Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2005; 97: 152-153; author reply 153-154.
28. Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G, Bjorntorp P: The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 2003; 11: 578-585.
29. Combarros O, Riancho JA, Infante J, Sanudo C, Llorca J, Zarrabeitia MT, Berciano J: Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord 2005; 20: 153-157.
30. Combarros O, Sanchez-Juan P, Riancho JA, Mateo I, Rodriguez-Rodriguez E, Infante J, Garcia-Gorostiaga I, Vazquez-Higuera JL, Berciano J: Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk. J Neural Transm 2008; 115: 863-867.
31. Han MR, Schellenberg GD, Wang LS: Genome-wide association reveals genetic effects on human Aβ42 and tau protein levels in cerebrospinal fluids: a case control study. BMC Neurol 2010; 10: 90.